In multivariable external testing, tumor structure habitat phenotypes from pre-treatment MRI revealed more than a doubling of recurrence risk for women with stage 2 and stage 3 breast cancer.
|Articles|November 26, 2013
MIM Software to Highlight MIMcloud Portal
Advertisement
MIM Software Inc. will be highlighting at RSNA 2013 a cloud-based option for their entire MIM software suite.
The MIMcloud Portal will allow any physician or healthcare professional to access MIM anywhere on most computers with Internet access. With this portal, al processing is done in the cloud and the user’s computer only functions as a display with interaction, the company said. All images are encrypted and meet HIPAA requirements.
The MIMcloud Portal can be used from the company’s thin client server or from a client-hosted on-site server, the company said. In either case, the MIM licensing system remains the same, and there are significant benefits and cost savings.
Advertisement
Related to this article
Could a la carte pricing be a consideration in improving revenue for radiologists in private practice?
Catch up on a variety of FDA news in radiology from the past week.
Catch up on the top radiology content of the past week.
Reportedly one of the first FDA-cleared chest X-ray AI software platforms derived from a foundation model, the Chest Xray software facilitates detection and localization of lung nodules, pneumothorax, mediastinal abnormalities and other thoracic abnormalities.
Incorporating structural MRI to improve PET imaging resolution, the MICSI-PET software also offers automated Centiloid quantification from amyloid PET scans.
Emerging research demonstrates the increasing stability of attenuation on clinically relevant VMIs with photon-counting CT and a redefined role of kV that may have implications for longitudinal quantitative CT.
For patients with intermediate-risk prostate cancer, those with lower apparent diffusion coefficient (ADC) values on pre-treatment DWI MRI had a fourfold higher prevalence of distant metastasis in a study with a 10.3-year median follow-up.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears Software That Combines MRI Enhancement of PET Imaging with Automated Quantification of Amyloid and Tau PET
2
Is Private Practice Radiology as Important as an Amusement Park?
3
Can MRI-Derived Tumor Habitat Subregions Bolster Recurrence Risk Stratification in Stage 2 and 3 Breast Cancer Cases?
4
Radiology Roundup of FDA News: September 13 — September 19
5